JAGX Jaguar Health Inc.

-0.05  -16%
Previous Close 0.33
Open 0.33
Price To Book 1.12
Market Cap 12702848
Shares 45,383,522
Volume 10,289,915
Short Ratio
Av. Daily Volume 4,480,729

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 interim data due 1Q 2019.
Mytesi (crofelemer)
Cancer related diarrhea (CRD)
Protocol development for discussions with FDA.
Mytesi (crofelemer)
Inflammatory bowel disease (IBD)

Latest News

  1. Jaguar Completes Filing of CMC Technical Section with FDA for Use of Canalevia for Treatment of Chemotherapy-Induced Diarrhea in Dogs
  2. Four Healthcare Stocks Heating Up On Monday
  3. Jaguar Health, Inc. Reports Voting Results from February 28, 2019 Special Meeting of Stockholders
  4. Jaguar Health Announces Adjournment of Special Meeting of Stockholders Until Thursday, February 28, 2019
  5. What Kind Of Shareholders Own Jaguar Health, Inc. (NASDAQ:JAGX)?
  6. With the Addition of Mytesi to the Formulary for Florida's AIDS Drug Assistance Program (ADAP), Approximately 86% of ADAP-Eligible US Lives Now Have Access to Jaguar Health's FDA-Approved Drug Product
  7. Jaguar Health to Present at Noble Capital Markets Annual Investor Conference January 28 in Fort Lauderdale
  8. Jaguar Health Receives First Order for First-Generation of Equilevia, the Company's Non-Prescription, Personalized, Premium Product for Total Gut Health in High-Performance Equine Athletes
  9. Jaguar Health Provides Fourth Quarter 2018 Commercial Sales Updates
  10. Jaguar Health to Present at Biotech Showcase 2019 in San Francisco
  11. Jaguar Health to Host Investor Call January 7th at 8 a.m. Eastern to Review 4Q'18 Performance
  12. Jaguar Health, Inc. Engages T.R. Winston & Company to Advise on Collaboration, Licensing and Development Activities Related to Mytesi and Crofelemer
  13. Jaguar Health, Inc. Reports Third-Quarter 2018 Results
  14. Reminder: Jaguar Health, Inc. Will Release 3Q'18 Financial Results After Market on November 14th
  15. The Brilliance Behind a Global Operator of Crypto Exchanges BitMax: Understanding the Trans-Fee Mining Model
  16. Jaguar Health, Inc. Expects to File Third-Quarter 2018 Financial Results November 14th
  17. Jaguar Health, Inc. to Host Investor Meetings at Dawson James Small Cap Growth Conference Tuesday, October 30, 2018 in Jupiter, Florida
  18. Jaguar Health Announces Pricing of $9 Million Underwritten Public Offering
  19. These Biotech and Cannabis Stocks Are Skyrocketing